Prognostic Stage III Breast Cancer AJCC v8 Withdrawn Phase 2 Trials for Cyclophosphamide (DB00531)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Withdrawn2 IdentifierTitlePurposeDrugs
NCT05177796Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast CancerTreatment